Donald Hooker
Stock Analyst at Keybanc
(2.49)
# 2,349
Out of 5,141 analysts
81
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $4.74 | +2,009.70% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $168.92 | +130.88% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $202.41 | -16.01% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $165.62 | +75.10% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $12.71 | +474.35% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $3.42 | +952.63% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $5.45 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $180.31 | +95.77% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $78.90 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $73.78 | +13.85% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $2.79 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $282.67 | -39.86% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $99.70 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $0.88 | +5,127.27% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $453.77 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $4.74
Upside: +2,009.70%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $168.92
Upside: +130.88%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $202.41
Upside: -16.01%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $165.62
Upside: +75.10%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $12.71
Upside: +474.35%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $3.42
Upside: +952.63%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $5.45
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $180.31
Upside: +95.77%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $78.90
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $73.78
Upside: +13.85%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $2.79
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $282.67
Upside: -39.86%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $99.70
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $0.88
Upside: +5,127.27%
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $453.77
Upside: -